A largely random AAV integration profile after LPLD gene therapy

Abstract

The clinical application of adeno-associated virus vectors (AAVs) is limited because of concerns about AAV integration-mediated tumorigenicity.

We performed integration-site analysis after AAV1-LPL(S447X) intramuscular injection in five lipoprotein lipase-deficient subjects, revealing random nuclear integration and hotspots in mitochondria.

We conclude that AAV integration is potentially safe and that vector breakage and integration may occur from each position of the vector genome. Future viral integration-site analyses should include the mitochondrial genome.

Read the full publication here.

Related Publications

Discover more publications from the GeneWerk team

Systematic comparative study of computational methods for…

Abstract High-throughput sequencing technologies have exposed the possibilities for the in-depth evaluation of T-cell...
View

Real-Time Definition of Non-Randomness in the Distribution…

Abstract Features such as mutations or structural characteristics can be non-randomly or non-uniformly distributed...
View

Preclinical evaluation of efficacy and safety of…

Abstract A previously published clinical trial demonstrated the benefit of autologous CD34(+) cells transduced...
View

Polyclonal long-term repopulating stem cell clones in…

Abstract Hematopoietic bone marrow stem cells generate differentiated blood cells and, when transplanted, may...
View

Want to get in touch?

Click the button below if you want to find out more about the services
we offer or discuss your next project.

Contact us
I agree to the Privacy Policy and Terms of Service.